Molina Healthcare — Jul 7, 2025 release

RECONCILIATION OF PRELIMINARY UNAUDITED NON-GAAP FINANCIAL MEASURES 2025 GUIDANCE (in millions, except per diluted share amounts; unaudited)       Amount     Per Diluted Share (4)   GAAP Net income   $1,045 to $1,099     $19.32 to $20.32   Adjustments:                 Amortization of intangible assets     ~86       ~1.59   Acquisition-related expenses     ~66       ~1.23   Other     ~2       ~0.03   Subtotal, adjustments     ~154       ~2.85   Income tax effect (3)     ~(36 )     ~(0.67 ) Adjustments, net of tax     ~118       ~2.18   Adjusted net income   $1,163 to $1,217     $21.50 to $22.50     (3) Income tax effect calculated at the statutory tax rate of approximately 23.7%. (4) Computations assume approximately 54.1 million diluted weighted average shares outstanding.   The Company believes that certain non-GAAP (generally accepted accounting principles) financial measures are useful supplemental measures to investors in comparing the Company’s performance to the performance of other public companies in the health care industry. The non-GAAP financial measures are also used internally to enable management to assess the Company’s performance consistently over time. These non-GAAP financial measures, presented below, should be considered as supplements to, and not as substitutes for or superior to, GAAP measures.   Adjustments  represent additions and deductions to GAAP net income as indicated in the table below, which include the non-cash impact of amortization of acquired intangible assets, acquisition-related expenses, and the impact of certain expenses and other items that management believes are not indicative of longer-term business trends and operations.   Adj